In this study has been described the potential for Elastase, an enzyme present in pancreatic juice, which participates in the decomposition of mucopolysaccharide or elastin to improve at least two factors associated with the developement of arteriosclerosis, i. e., metabolism of the arterial wall and metabolism of lipids.
It should be pointed out that any discussion of the influence of serum lipids on arteriosclerosis is not complete, if it dose not take into account a different effect of its carrier, lipoprotein, on the developement of this disease. With this consideration in mind, the influence of Elastase on plasma lipoprotein metabolism in the rabbits with normolipemia was investigated by the double isotope method in the present study.
Elastase (Eisai Co., Ltd.) was administrated orally to rabbits in a dose of 1050 Elastase units for 7 consecutive days. Ten days before administration of Elastase, 15μCi of
3H-1, 2-cholesterol was administered intravenously, and after 7 days of administration of Elastase, 70μCi of
14C-2-glycine was administered intravenously 6 hours before blood collection. And the blood levels of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) were determined by ultracentrifugation of blood samples.
When the influence of Elastase is viewed from the standpoint of the ratio of lipid to protein in each lipoprotein, the ratio of triglyceride to protein in VLDL is significantly higher (p<0.05), and the ratio of cholesterol to protein in LDL is also higher than in the controls. On the other hand, the specific activity of
3H-cholesterol in VLDL is lower in experimental animals than in the control, and there is no difference in its activity in LDL between the experimental and control animals. Similarly the incorporation of
14C-glycine into lipoproteins shows a lower value for VLDL-protein in the experimental animals, and presents no difference for LDL-protein between the experimental and control animals.
These facts, especially result in a high rate of metabolic turnover inspite of an increase in triglyceride against protein-unit in VLDL, suggest that the transformation of VLDL into LDL was promoted by Elastase. The increased ratio of cholesterol to triglyceride in LDL might serve as an indication that the decomposition of VLDL-triglyceride or early course of transformation of VLDL into LDL was pronoted by Elastase. Conversely, the decreased ratio of VLDL to LDL in
14C-protein would support the above view.
Importance is attached to disorders of lipoprotein metabolism, especially ones associated with various enzymes as one of the causes of hyperlipemia. In the light of the fact that Elastase exerted the above-mentioned effect in normal serum lipids, it can be expected that Elastase not only improves but also arrests hyperlipemia.
View full abstract